{"id":8537,"date":"2015-07-01T20:16:47","date_gmt":"2015-07-01T19:16:47","guid":{"rendered":"https:\/\/mileon.wordpress.com\/?p=8537"},"modified":"2015-07-01T20:16:47","modified_gmt":"2015-07-01T19:16:47","slug":"tratamiento-endovascular-del-ictus-agudo","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/maitines\/2015-07-01\/tratamiento-endovascular-del-ictus-agudo\/","title":{"rendered":"Tratamiento endovascular del ictus agudo."},"content":{"rendered":"<p style=\"text-align:justify;\"><a href=\"https:\/\/mileon.files.wordpress.com\/2015\/07\/imagen11.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"  wp-image-8538 alignright\" src=\"https:\/\/mileon.files.wordpress.com\/2015\/07\/imagen11.jpg?w=250\" alt=\"Imagen1\" width=\"172\" height=\"205\" \/><\/a>La Dra. Lidia Lara, residente de Neurolog\u00eda, revisa las evidencias actuales que avalan la terapia fibrinol\u00edtica junto con el tratamiento endovascular en el ictus. Se hace una descripci\u00f3n de los \u00faltimos ensayos publicados, sobre todo el MrClean, que demuestran conseguir la reperfusi\u00f3n del vaso afectado en un alto porcentage y mejorar la evoluci\u00f3n cl\u00ednica. Probablemente los trabajos actuales eligen mejor a los pacientes candidatos a estas t\u00e9cnicas y la exigencia de tiempo de actuaci\u00f3n es m\u00e1s extricta (6 horas).<\/p>\n<p style=\"text-align:justify;\">Ver la presentaci\u00f3n completa pinchando <em><strong><a href=\"https:\/\/drive.google.com\/file\/d\/0BxXYCqMXR4ZaMzQ4d1o3WEh2akU\/view?usp=sharing\">AQU\u00cd<\/a><\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Dra. Lidia Lara, residente de Neurolog\u00eda, revisa las evidencias actuales que avalan la terapia fibrinol\u00edtica junto con el tratamiento endovascular en el ictus. Se hace una descripci\u00f3n de los \u00faltimos ensayos publicados, sobre todo el MrClean, que demuestran conseguir la reperfusi\u00f3n del vaso afectado en un alto porcentage y mejorar la evoluci\u00f3n cl\u00ednica. Probablemente [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[715],"tags":[],"class_list":["post-8537","post","type-post","status-publish","format-standard","hentry","category-maitines"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/8537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=8537"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/8537\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=8537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=8537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=8537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}